Merit Medical Financials
MMSI Stock | USD 104.75 0.28 0.27% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.72 | 0.6847 |
|
| |||||
Current Ratio | 3.38 | 5.4453 |
|
|
The financial analysis of Merit Medical is a critical element in measuring its lifeblood. Investors should not minimize Merit Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Merit | Select Account or Indicator |
Understanding current and past Merit Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Merit Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Merit Medical's assets may result in an increase in income on the income statement.
Merit Medical Stock Summary
Merit Medical competes with Teleflex Incorporated, Cooper Companies,, West Pharmaceutical, ICU Medical, and AngioDynamics. Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah. Merit Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6446 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US5898891040 |
CUSIP | 589889104 |
Location | Utah; U.S.A |
Business Address | 1600 West Merit |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.merit.com |
Phone | 801 253 1600 |
Currency | USD - US Dollar |
Merit Medical Key Financial Ratios
Return On Equity | 0.094 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.11 % | ||||
Price To Sales | 4.62 X | ||||
Revenue | 1.26 B |
Merit Medical Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.8B | 1.7B | 1.6B | 1.7B | 2.3B | 2.4B | |
Other Current Liab | 108.0M | 99.0M | 148.3M | 112.2M | 120.4M | 126.5M | |
Net Debt | 479.4M | 378.2M | 247.3M | 210.3M | 302.2M | 317.3M | |
Retained Earnings | 368.2M | 357.8M | 406.3M | 480.8M | 575.2M | 603.9M | |
Net Receivables | 168.5M | 158.0M | 172.8M | 178.4M | 189.3M | 198.7M | |
Inventory | 225.7M | 198.0M | 221.9M | 266.0M | 303.9M | 319.1M | |
Other Current Assets | 12.5M | 16.8M | 19.7M | 26.2M | 26.2M | 27.5M | |
Total Liab | 807.4M | 705.8M | 608.5M | 519.6M | 1.1B | 1.2B | |
Total Current Assets | 454.5M | 429.7M | 482.2M | 529.1M | 1.1B | 1.2B | |
Short Term Debt | 19.1M | 33.3M | 29.8M | 33.3M | 12.1M | 10.5M | |
Intangible Assets | 445.3M | 367.9M | 319.3M | 275.9M | 325.9M | 342.2M | |
Cash | 44.3M | 56.9M | 67.8M | 58.4M | 589.1M | 618.6M | |
Accounts Payable | 54.6M | 49.8M | 55.6M | 68.5M | 65.9M | 69.2M | |
Common Stock | 587.0M | 606.2M | 641.5M | 675.2M | 638.2M | 670.1M | |
Other Liab | 120.7M | 102.7M | 76.3M | 52.4M | 60.3M | 35.4M | |
Other Assets | 28.1M | 227.7M | 47.5M | 31.9M | 36.7M | 25.7M | |
Long Term Debt | 432.0M | 343.7M | 234.4M | 186.8M | 823.0M | 864.2M | |
Good Will | 353.2M | 363.5M | 361.7M | 359.8M | 382.2M | 401.4M | |
Net Tangible Assets | 151.4M | 227.1M | 358.8M | 508.7M | 585.0M | 614.3M | |
Long Term Debt Total | 432.0M | 343.7M | 234.4M | 186.8M | 214.8M | 281.4M |
Merit Medical Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 12.4M | 10.0M | 5.3M | 6.3M | 15.5M | 16.3M | |
Total Revenue | 994.9M | 963.9M | 1.1B | 1.2B | 1.3B | 1.3B | |
Gross Profit | 432.4M | 401.2M | 485.3M | 519.1M | 583.9M | 613.1M | |
Operating Income | (65.7M) | (62.6M) | 60.9M | 87.6M | 123.9M | 130.1M | |
Ebit | (65.7M) | (4.1M) | 57.7M | 89.0M | 130.2M | 136.7M | |
Ebitda | 38.6M | 102.7M | 153.5M | 181.2M | 231.4M | 243.0M | |
Cost Of Revenue | 562.5M | 562.7M | 589.4M | 631.9M | 673.5M | 707.2M | |
Income Before Tax | 2.2M | (13.2M) | 53.9M | 82.6M | 112.1M | 117.7M | |
Net Income | 5.5M | (9.8M) | 48.5M | 74.5M | 94.4M | 99.1M | |
Income Tax Expense | (3.3M) | (3.4M) | 5.5M | 8.1M | 17.7M | 18.6M | |
Research Development | 65.6M | 57.5M | 71.2M | 75.5M | 82.7M | 86.9M | |
Tax Provision | (3.3M) | (3.4M) | 5.5M | 8.1M | 10.6M | 11.1M | |
Interest Income | 291K | 604K | 769K | 439K | 656K | 958.0K | |
Net Interest Income | (12.7M) | (9.4M) | (4.5M) | (5.9M) | (12.0M) | (12.6M) |
Merit Medical Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (27.0M) | 29.4M | (25.2M) | (47.9M) | (32.1M) | (30.5M) | |
Change In Cash | (23.0M) | 12.6M | 10.8M | (7.2M) | 528.6M | 555.0M | |
Free Cash Flow | (3.7M) | 116.0M | 119.3M | 69.3M | 108.5M | 113.9M | |
Depreciation | 104.4M | 106.8M | 95.8M | 92.2M | 101.3M | 106.4M | |
Other Non Cash Items | 26.8M | 31.0M | 9.4M | 15.9M | 10.8M | 11.3M | |
Capital Expenditures | 81.5M | 49.3M | 27.9M | 45.0M | 36.7M | 29.4M | |
Net Income | 5.5M | (9.8M) | 48.5M | 74.5M | 94.4M | 99.1M | |
End Period Cash Flow | 44.3M | 56.9M | 67.8M | 60.6M | 589.1M | 618.6M | |
Change To Netincome | 22.8M | 175.1M | 20.8M | 39.8M | 45.7M | 30.8M | |
Investments | (134.5M) | 250K | (37.2M) | (57.4M) | (184.3M) | (175.1M) | |
Net Borrowings | 44.5M | (88.4M) | (108.5M) | (44.9M) | (40.4M) | (38.4M) |
Merit Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Merit Medical's current stock value. Our valuation model uses many indicators to compare Merit Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merit Medical competition to find correlations between indicators driving Merit Medical's intrinsic value. More Info.Merit Medical Systems is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merit Medical Systems is roughly 2.06 . As of now, Merit Medical's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Merit Medical's earnings, one of the primary drivers of an investment's value.Merit Medical Systems Systematic Risk
Merit Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Merit Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Merit Medical Systems correlated with the market. If Beta is less than 0 Merit Medical generally moves in the opposite direction as compared to the market. If Merit Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Merit Medical Systems is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Merit Medical is generally in the same direction as the market. If Beta > 1 Merit Medical moves generally in the same direction as, but more than the movement of the benchmark.
Merit Medical Thematic Clasifications
Merit Medical Systems is part of several thematic ideas from Health Management to Management. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasHealth Management | View | ||
Management | View | ||
Office Supplies | View | ||
Drugs | View | ||
Obamacare Repeal | View | ||
Trump Equities | View |
Today, most investors in Merit Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Merit Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Merit Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Merit Medical November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Merit Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Merit Medical Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Merit Medical Systems based on widely used predictive technical indicators. In general, we focus on analyzing Merit Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Merit Medical's daily price indicators and compare them against related drivers.
Downside Deviation | 1.0 | |||
Information Ratio | 0.0825 | |||
Maximum Drawdown | 6.42 | |||
Value At Risk | (1.23) | |||
Potential Upside | 2.11 |
Complementary Tools for Merit Stock analysis
When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |